Pharma 4.0 Digital Transformation Panel Discussion: Using Digital Technologies to Enhance Compliance in Pharma
This panel discussion reviews how digitalization, an important component of Pharma 4.0, will connect multiple sources of data to establish new levels of transparency and speed for a SMART manufacturing process.
Speakers include Craig Resnick from ARC Advisory Group, Richard Porter from Aspen Technology and Michael Connor from WSP USA. Hear industry experts discuss:
- Automated data collection providing manufacturers with a more holistic production picture
- Replacement of paper processing of records by electronic logs
- How a greater quality and scope of available information incorporating regulatory and quality factors allows for improved performance, product quality and customer service
- How machine learning and AI can provide greater predictability and decrease unplanned downtime
Watch this panel discussion to learn more.
Related Content
The COVID-19 pandemic highlighted the need for agility and resiliency within the supply chain for pharmaceutical companies. It is clear that speed to market will remain a top business imperative as we move into the next normal for pharma.
Interview with an Expert:
Navigating Pharma Scheduling Challenges During Periods of Volatility and Supply Chain Disruptions
Video:
Optimizing Outcomes Across the Pharma Value Chain Network
Case Study:
GSK Creates a Future-Ready Supply Chain with Predictive and Prescriptive Maintenance